Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Gene Variant Protects Against Geographic Atrophy in Macular Degeneration
Link ID 8337
Title Gene Variant Protects Against Geographic Atrophy in Macular Degeneration
Url http://www.medscape.com/viewarticle/579936?src=rss
Description TLR3 is the first gene associated specifically with the dry form of age-related macular degeneration. Medscape Medical News
Category Articles > Ophthalmology
Keywords
Date Sep 3, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Ophthalmology
1. Refractive Change Following Pseudophakic Vitrectomy
  This retrospective review assessed the occurrence and magnitude of refractive change in pseudophakic eyes undergoing 20 gauge pars plana vitrectomy without scleral buckling.
BMC Ophthalmology
Category:   Articles > Ophthalmology


2. Human Thelaziasis, Europe
  Thelazia callipaeda eyeworm is a nematode transmitted by drosophilid flies to carnivores in Europe. There are 4 reported cases of Thelaziasis callipaeda infection in human patients.
Emerging Infectious Diseases
Category:   Articles > Ophthalmology


3. 34th Annual North American Neuro-Ophthalmology Society (NANOS) Meeting
  NANOS 2008 focused on the neurologic, vascular, and ophthalmic conditions that contribute to neuro-ophthalmic disorders. Medscape Nephrology
Category:   Articles > Ophthalmology


4. Genetic Variation in Complement Regulator Linked to AMD
  Genetic variation in the serpin peptidase inhibitor, clade G member 1 (SERPING1) is associated with age-related macular degeneration (AMD), according to cohort studies conducted in the UK and the US. Reuters Health Information
Category:   Articles > Ophthalmology


5. Optic Pathway Gliomas: A Review
  Chemotherapy is the first-line treatment for progressive optic pathway tumors, and radiation therapy is reserved for patients with progressive disease who are older than 5–7 years. Surgery is reserved for large tumors causing mass effect or hydrocephalus.
Neurosurgical Focus
Category:   Articles > Ophthalmology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS